Page 661 - Cardiac Nursing
P. 661

CHAPTER 26 / Mechanical Circulatory Assist Devices  637


            27. Radovancevic, B., Vrtovec, B., de Kort, E., et al. (2007). End-organ func-  41. Frazier, O. H., Myers, T. J., Gregoric, I. D., et al. (2002). Initial clinical
              tion in patients on long-term circulatory support with continuous- or  experience with the Jarvik 2000 implantable axial-flow left ventricular
              pulsatile-flow assist devices. The Journal of Heart and Lung Transplantation,  assist system. Circulation, 105, 2855–2860.
              26, 815–818.                                     42. Koerner, M. M., & Jahanyar, J. (2008). Assist devices for circulatory sup-
            28. Feller, E. D., Sorensen, E. N., Haddad, M., et al. (2007). Clinical out-  port in therapy-refractory acute heart failure. Current Opinion in Cardiol-
              comes are similar in pulsatile and nonpulsatile left ventricular assist device  ogy, 23, 99–406.
              recipients. The Annals of Thoracic Surgery, 83, 1082–1088.  43. Copeland, J. G., Smith, R. G., Arabia, F. A., et al. (2004). Cardiac re-
            29. Siegenthaler, M. P., Brehm, K., Strecker, T., et al. (2004). The Impella  placement with a total artificial heart as a bridge to transplantation. The
              recover microaxial left ventricular assist device reduces mortality for  New England Journal of Medicine, 351, 859–867.
              postcardiotomy failure: A three-center experience. The Journal of Thoracic  44. Simon, D., Fischer, S., Grossman, A., et al. (2005). Left ventricular assists
              and Cardiovascular Surgery, 127, 812.               device-related infection: Treatment and outcome. Clinical Infectious Disease,
            30. Jurmann, M. J., Siniawski, H., Erb, M., et al. (2004). Initial experience  40, 1108.
              with miniature axial flow ventricular assist devices for postcardiotomy  45. Reilly, M. P., Wiegers, S. E., Cucchiara, A. J., et al. (2000). Frequency, risk
              heart failure. The Annals of Thoracic Surgery, 77, 1642.  factors, and clinical outcomes of left ventricular assist device-associated
            31. Thiele, H., Smalling, R. W., Schuler, G. C. (2007). Percutaneous left   ventricular thrombus. The American Journal of Cardiology, 86, 1156.
              ventricular assist devices in acute myocardial infarction complicated by  46. Itescu, S., Ankersmit, J. H., Kocher, A. A., et al. (2000). Immunobiol-
              cardiogenic shock. European Heart Journal, 28, 2057–2063.  ogy of left ventricular assist devices. Progress in Cardiovascular Diseases,
            32. Thiele, H., Sick, P., Boudriot, E., et al. (2005). Randomized comparison  43, 67.
              of intra-aortic balloon support with a percutaneous left ventricular assist  47. Dipla, K., Mattiello, J. A., Jeevanandam, V., et al. (1998). Myocyte recov-
              device in patients with revascularized acute myocardial infarction compli-  ery after mechanical circulatory support in humans with end-stage heart
              cated by cardiogenic shock. European Heart Journal, 26, 1276.  failure. Circulation, 97, 2316.
            33. Noon, G. P., Lafuente, J. A., Irwin, S. (1999). Acute and temporary ven-  48. Heerdt, P. M., Holmes, J. W., Cai, B., et al. (2000). Chronic unloading by
              tricular support with BioMedicus centrifugal pump. The Annals of Tho-  left ventricular assist device reverses contractile dysfunction and alters gene
              racic Surgery, 68, 650–654.                         expression in end-stage heart failure. Circulation, 102, 2713.
            34. Rastan, A. J., Lachmann, N., Walther, T., et al. (2006). Autopsy findings  49. Bruckner, B. A., Stetson, S. J., Perez-Verdia, A., et al. (2001). Regression
              in patients on postcardiotomy extracorporeal membrane oxygenation  of fibrosis and hypertrophy in failing myocardium following mechanical
              (ECMO). The International Journal of Artificial Organs, 29, 1121–1131.  circulatory support. The Journal of Heart and Lung Transplantation, 20,
            35. Samuels, L. E., Holmes, E. C., Garwood, P., et al. (2005). Initial experi-  457.
              ence with the Abiomed AB5000 ventricular assist device system. The   50. Madigan, J. D., Barbone, A., Choudhri, A. F., et al. (2001). Time course
              Annals of Thoracic Surgery, 80, 309–312.            of reverse remodeling of the left ventricle during support with a left ven-
            36. Maroney, D. A., & Reedy, J. E. (1994). Understanding ventricular assist  tricular assist device. The Journal of Thoracic and Cardiovascular Surgery,
              devices: A self-study guide. Journal of Cardiovascular Nursing, 8(2), 1–12.  121, 902.
            37. Shinn, J. A., & Oyer, P. E. (1993). Novacor ventricular assist system. In   51. Ogletree-Hughes, M. L., Stull, L. B., Sweet, W. E., et al. (2001). Me-
              S. Quaal (Ed.),  Cardiac mechanical assist beyond balloon pumping  chanical unloading restores beta-adrenergic responsiveness and reverses
              (pp. 99–115). St. Louis: C.V. Mosby.                receptor downregulation in the failing human heart. Circulation 104,
            38. Hunt, S. A., Frazier, O. H., & Myers, T. J. (1998). Mechanical circulatory  881.
              support and cardiac transplantation. Circulation, 97, 2079–2090.  52. Vatta, M., Stetson, S. J., Perez-Verdia, A., et al. (2002). Molecular re-
            39. Rose, E. A., Gelijns, A. C., Moskowitz, A. J., et al. (2001). Long-term me-  modelling of dystrophin in patients with end-stage cardiomyopathies
              chanical left ventricular assistance for end-stage heart failure. The New  and reversal in patients on assistance-device therapy. The Lancet, 359,
              England Journal of Medicine, 345(20), 1435–1443.    936.
            40. Miller, L., Pagani, F., Russell, S., et al. (2007). Use of a continuous-flow  53. Birks, E. J., Tansley, P. D., Hardy, J., et al. (2006). Left ventricular assist
              device in patients awaiting heart transplantation. The New England Jour-  device and drug therapy for the reversal of heart failure. The New England
              nal of Medicine, 357, 885–896.                      Journal of Medicine, 355, 1873.
   656   657   658   659   660   661   662   663   664   665   666